First study that demonstrates that the MCG improves the control of diabetes, regardless of the type of treatment.
Technology in diabetes has increased and improved in recent years.We have improvements in technology, more acceptance and more evidence of its benefits.One of the questions we ask about continuous glucose meters is:
Is it equally effective in those patients with multiple insulin injections as in patients with insulin pump?
With the question in mind, the Diamond study analyzed about 150 people with type 1 diabetes that analyzed their blood glucose levels several times per day, and used multiple doses of insulin, not insulin pumps.They were randomly assigned to continuous glucose meters or were asked to continue their previous blood self -control scheme.
What we found was really interesting.There was a significant improvement in both groups, probably due to the effect of the study, but the improvement was more evident in those with continuous glucose measurement.The difference in glycosylated hemoglobin was more than 0.6%.In this way, the impression that continuous MCG glucose measurement can benefit those with type 1 diabetes that use multiple insulin dose without insulin pump can be confirmed.
Does this change the way we treat our patients?Should we change the moment in which we use the continuous glucose measurement since it has already become very improved technology in terms of reliability of results and convenience of use?
On the other hand, we recently know (July 2016) that the FDA has allowed to adjust the doses of insulin according to the results of the MCG, visit Link.
what we found was really interesting
I think we will find that continuous glucose measurement, if not for economic limitations, should be initiated in all patients with diabetes, especially in insulin treaties, modifying the habit of first starting with an insulin bomb and later theMCG, and that will eventually be invested according to our opinion.
There are many reasons to have patients who first use the MCG, and particularly if it is due to their preference.The most important thing is the information you receive with the MCG, you always have to respect and allow the informed patient to make the decision.Patients learn a lot from what they see as a result of their diet.But what happens in certain cases after performing physical activity or after the injection of insulin, which despite having a good diabetological education and the correct management of all the MCG information are not achieved by the control objectives.
What we still do not discuss is the quality of life.There are many evidences, indications and some studies that show that with the MCG the quality of life is also improved.
Source: Medscape Diabetes & AMP;Endocrinology 2016
